Anaphylaxis: NICE Quality Standard Guidance

Introduction 

Anaphylaxis is a medical emergency that demands rapid intervention. NICE’s Quality Standard QS119 provides a clear framework to guide healthcare professionals in managing this critical condition effectively. 

Key Areas of the Guidance 

• Prompt Recognition and Treatment: The guidance stresses the importance of recognising the signs and symptoms of anaphylaxis quickly. Immediate administration of intramuscular adrenaline is recommended as the first-line treatment. 

• Post-Emergency Care: After the initial emergency response, the guidance highlights the need for further monitoring in a healthcare setting. This ensures the patient’s stability and addresses any biphasic reactions, where symptoms return after initial improvement. 

• Education and Support: The guidance underscores the importance of educating patients and caregivers on recognising anaphylaxis symptoms and administering adrenaline. Patients should be provided with an adrenaline auto-injector and trained in its use. 

Prevention and Long-term Management 

• Risk Identification: Identifying individuals at risk of anaphylaxis, such as those with known severe allergies, is crucial. Healthcare professionals should conduct thorough risk assessments to guide prevention strategies. 

• Allergy Specialist Referral: NICE recommends referring patients who have experienced anaphylaxis to an allergy specialist for comprehensive assessment and ongoing management. This helps in identifying specific triggers and tailoring preventive measures. 

Conclusion 

NICE’s Quality Standard QS119 provides vital guidance for the prompt and effective management of anaphylaxis. By standardising care practices, educating patients, and focusing on prevention, this guidance aims to reduce the risk of severe outcomes and improve the quality of life for individuals with severe allergies. 

Read more: Overview | Anaphylaxis | Quality standards | NICE

Read more articles: Ashtons Resources